The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3+-pretreatment in the rat in vivo and in vitro: Are antioxidant properties of metallothionein more relevant than platinum binding?
- 1 February 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (3) , 369-375
- https://doi.org/10.1016/0006-2952(91)90533-b
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Can Bismuth decrease the kidney toxic effect of Cis-platinum?European Journal of Cancer and Clinical Oncology, 1989
- Pharmacokinetics and Toxicity of Bismuth CompoundsDrug Safety, 1989
- High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observationsCancer Chemotherapy and Pharmacology, 1989
- Cisplatin nephrotoxicityCancer Chemotherapy and Pharmacology, 1989
- Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heartToxicology, 1988
- Some procedures to reduce cis-platinum toxicity reduce antitumour activityCancer Treatment Reviews, 1987
- Cisplatin nephrotoxicity: insights into mechanismInternational Journal of Andrology, 1987
- The mechanism of action of platinum antitumor drugsPure and Applied Chemistry, 1987
- Cisplatinum: A review, with special reference to cellular and molecular interactionsInflammation Research, 1984
- The nephrotoxicity of cisplatinLife Sciences, 1983